IRWD
Ironwood Pharmaceuticals Inc
3.60$
-0.5%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | +3.5% | +15.4% | +85.5% | -30.7% | +10.0% | +21.3% | +19.6% | +85.6% | +14.6% | -14.7% | -45.2% | +21.3% | +38.9% | +101.5% | -2.3% | -57.2% | -25.5% | +13.1% | |
| – | – | -9.3% | +21.6% | +97.1% | -35.3% | +10.1% | +24.2% | +26.4% | +72.6% | -24.0% | -18.0% | -14.5% | +15.2% | +61.6% | +50.3% | +4.8% | -70.1% | -21.8% | +50.3% | |
| – | – | +8.5% | +81.8% | -64.0% | +96.9% | +56.6% | -44.8% | -1.6% | +251.7% | -79.3% | +132.8% | +37.7% | +2.2% | +105.8% | +70.2% | +5.8% | -86.0% | -3.9% | +143.3% | |
| – | – | -2.4% | +37.2% | +101.4% | -33.9% | +2.6% | +17.5% | +25.7% | +76.9% | -30.5% | -27.5% | -21.8% | +2.2% | +105.8% | +70.2% | +5.8% | -86.0% | -3.9% | +143.3% | |
| – | – | -72.1% | -26.7% | -44.5% | -77.5% | +128.1% | +116.1% | +704.2% | +111.0% | +19.0% | +26.7% | -1.5% | +44.8% | +4.4% | -6.8% | +1.2% | +11.8% | -36.6% | -42.9% | |
| – | – | – | – | – | – | – | +230.6% | -77.6% | -100.0% | – | -32.0% | -100.0% | – | -100.0% | +124,999,900.0% | +0.0% | -100.0% | – | – | |
| – | – | +493.2% | -8.3% | +52.4% | -2.2% | +11.6% | -0.4% | -20.2% | -29.3% | -2.7% | -15.8% | 0.0% | -28.0% | -28.2% | +156.7% | -72.6% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | +0.0% | +0.0% | +0.0% | +0.0% | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | -3.7% | – | – | – | – | – | – | -22.3% | -28.7% | |
| – | – | +18.1% | +24.2% | -69.2% | -30.1% | -13.4% | +180.4% | +1.8% | +113.9% | +22.7% | -7.4% | -11.3% | -6.1% | +0.1% | +4.9% | -14.0% | +82.4% | -20.2% | +1.0% | |
| – | – | +30.8% | +44.1% | +14.2% | +1.1% | -15.7% | -25.3% | +47.5% | +26.3% | +19.2% | -27.5% | +81.0% | -65.8% | -21.4% | +402.6% | -84.2% | +981.7% | -85.9% | +523.5% | |
| – | – | +5.4% | +50.6% | -87.7% | +18.3% | +12.0% | +336.4% | +1,090.7% | +122.9% | -79.4% | -34.5% | +1,068.2% | -97.6% | +172.9% | +3,735.8% | -97.4% | +6,512.9% | -98.4% | +6,263.5% | |
| – | – | -33.1% | +27.3% | -9.5% | +49.6% | +237.6% | -53.1% | -4.2% | -12.0% | +106.1% | -9.9% | -6.7% | -63.2% | -88.0% | +41.5% | -48.3% | +1,521.1% | -72.8% | +36.2% | |
| – | – | -45.8% | +76.8% | -79.1% | +7.4% | -27.0% | +56,611.7% | -7.1% | +117.8% | +3.7% | +8.1% | -7.6% | +11.4% | +5.5% | -21.6% | +17.5% | +25.8% | +17.2% | -34.1% | |
| – | – | – | – | – | -31.1% | +31.1% | -73.5% | +131.7% | +7.4% | -29.9% | -85.2% | -2,094.0% | – | – | +867.3% | +7.7% | -153.1% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -20.4% | -7.7% | +0.0% | +28.5% | +11.4% | +6.5% | +8.9% | +18.1% | +3.9% | +2.6% | +2.1% | +2.4% | +2.2% | +3.0% | +2.3% | +13.3% | -16.6% | +3.0% | +11.0% |
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.